Pfizer has announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in...
According to a published scientific study from the Shiraz University of Medical Sciences, two to three months after a covid-19 infection, 20-30% of people who battled the virus may still experience brain fog, which might linger for...
In this edition of CEO Corner, we speak with Devon Price and Peter Bayne, Co-Founders, and owners of VitaNav, a functional beverage company, whose main product, Kenetik, is a ketone-based beverage. VitaNav was founded in 2018, and...
An Alzheimer’s drug that is being developed by Biogen and Eisai is showing some positive results. The newly developed drug that is currently in a phase three trial showed that the experimental monoclonal antibody reduced cognitive decline...
A large, nationwide study from Taiwan shows that people with a specific type of glaucoma, called normal-tension glaucoma, are at high risk for developing Alzheimer’s disease. The researchers say people with this type of glaucoma should be screened...
Researchers at the University of British Columbia have discovered a key vulnerability across all major variants of the SARS-CoV-2 virus, including the recently emerged BA.1 and BA.2 Omicron subvariants.
The weakness can be targeted...
Monod Bio, a life sciences company developing custom diagnostic biosensors that emit light to detect specific biomolecules of interest, has raised a $25M seed financing round. The round was led by Matrix Capital, with participation from the...
A review of studies about the effect of SARS-CoV-2—the virus that causes COVID-19—on the olfactory system introduces questions about whether loss of smell associated with COVID-19 infection may increase the risk of developing dementia later in life. The...
A paper in the New England Journal of Medicine describes how an early trial for a drug to treat rectal cancer at Memorial Sloan Kettering Cancer Center, led to remission in every participant. The small trial only...
The Food and Drug Administration is now investigating why hundreds of consumers have reported becoming ill after eating Lucky Charms cereal.
At least 139 consumers across the country reported they vomited and had...
Pfizer has announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP)...
